Corticosteroid withdrawal in solid organ transplantation

Transplantation Reviews

Volumn 12, Issue 3, 1998, Pages 140-147

  Stegall, Mark D ^a   Waclis, Michael ^b   Everson, Gregory T ^c  

^a Mayo Foundation and Clinic   (United States)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^c Foundation and Clinic   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0001197527     PISSN: 0955470X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0955-470X(98)80020-7     Document Type: Article

References (49)

1. Klintmalm GB, NeryJR, Husberg BS, et al: Rejection in liver transplantation. Hepatology 1989, 10:978
2. Mor E, Gonwa TA, Husber BS, et al: Late-onset acute rejection in orthotopic liver transplantation: associated risk factors and outcome. Transplantation 1992,54:821
3. TilneyNL: Transplantation and transplantation biology: from legend to reality, in Tilney NL, Strom TB, Paul LG (eds): Transplantation biology: cellular and molecular aspects. Philadelphia, Lippincott-Raven, 1996, p8
4. Sells RA: Cardiovascular complications following renal transplantation. Transplant Rev 1991, 11:111
5. Sinclair XRS for the Canadian Multicentre Transplant Study Group: I^ouxlose steroid therapy in cyclosporine-treated renal transplant recipients with well-functioning grafts. Can Med AssocJ 1992, 147:645
6. G. Opelz G: Effect of the maintenance immunosuppressive drug regimen on kidney transplant outcome. Transplantation 1994, 58:443
7. Ralcliffe PJ, Firth JD, Higgins RM, et al: Randomized controlled trial of complete steroid withdrawal in renal transplant patients receiving triple immunosuppression. Transplant Proc 1993,25:590
8. Stratta RJ, Armbrust MJ, Oh C-S, et al: Withdrawal of steroid immunosuppression in renal transplant recipients. Transplantation 1988,45:323
9. Pirsch JD, Armbrust MJ, Knechtle SJ, et al: Effect of steroid withdrawal on hypertension and cholesterol levels in living related recipients. Transplant Proc 1991,23:1363
10. Schulak JA, Mayes JT, Moritz CE, et al: A prospective randomized trial of prednisone versus no prednisone maintenance therapy in cyclosporine-treated and azathioprinetreated renal transplant patients. Transplantation 1990, 49:327
11. Hricik DE, \Vhalen CG, LautmanJ, et al: Withdrawal of steroids after renal transplantation: clinical predictors of outcome. Transplantation 1992,53:41
12. Griffin PJA, Gomes da Costa CA, Salaman JR: A controlled trial of steroids in cyclosporine-treated renal transplant recipients. Transplantation 1987,43:505
13. Braun UT, Popowniak KL, Nakamoto S, et al: The fate of renal allografts functioning for a minimum of 20 years: indefinite success of beginning of the end? Transplantation 1995,60:784
14. Vathsala A, Weinberg RB, Schoenberg L, et al: Lipid abnormalities in cyclosporine-prednisone-treated renal transplant recipients. Transplantation 1989,48:37
15. Ibels LS, Alfrey AC, \Veil R: Hyperlipidemia in adult, pédiatrie and diabetic renal transplant recipients. AmJ Med 1978,64:634
16. Gunnarson R, Lofmark R, Nondlander R, et al: Acute mj'ocardial infarction in renal transplant recipients: incidence. Eur Heart J 1984,5:218
17. Ingulli E, Tejani A, Markell M: The beneficial effects of steroid withdrawal on blood pressure and lipid profile in children posttransplantation in the cyclos|x>rine era. Transplantation 1993,55:1029
18. Hricick DE, Bartucci MR, MayesJT, et al: The effects of steroid withdrawal on the lipoprotein profiles of cyclosporinetreated kidney and kidney-pancreas transplant recipients. Transplantation 1992,54:868
19. Hricick DE, LautmanJ, Bartucci MR, et al: Variable effects of steroid withdrawal on blood pressure reduction in cyclosporine-treated renal transplant recipients. Transplantation 1992,53:1232
20. Hricick DE, Bartucci MR, Moir FJ, et al: Effects of steroid withdrawal on posttransplant diabetes mellitus in cjtlosjiorine-treated renal transplant recipients. Transplantation 1991,51:374
21. Tejani A, Butt KMH, Rapjoot D, et al: Strategies for optimizing growth in children with kidney transplants. Transplantation 1989,47:229
22. Reisman L, Lieberman KV, Burrow's I, et al: Follow-up of cjrlosporine-treated pédiatrie renal allograft recipients after cessation of prednisone. Transplantation 1990,49:76
23. Kahan BD, Kerman RH, Van Buren CT, et al: Clinical outcome in 36 patients after at least one and up to 5 years of steroid withdrawal based upon specific mixed lymphocyte reaction hyporesponsiveness toward the living related donor. Transplant Proc 1989,21:1579
24. Goulmy E, Bittner K, Blokland E, et al: Renal transplant patients with steroid withdrawal evaluated longitudinally for their donor-specific cytotoxic T cell reactivity. Transplantation 1991,52:1083
25. Chan G, Pescovitz M, Kalian BD, et al: Sirolimus permits early steroid withdrawal from a triple therapy renal prophylaxis regimen (abstr). Presented at the American Society of Transplant Surgeons Meeting, Chicago, IL, 1997
26. Grewal HP, Thistlewaite JR, Loss GE, et al: Corticosteroid cessation 1 week following renal transplantation using tacrolimus/mycophenolate mofetil based immunosuppression. Transplant Proc 1998, (in press)
27. Gjertson D\V, CeckaJM, Terasaki PI: The relative effects of FK506 and cyclosporine on short- and long-term kidney graft sur\i\-al. Transplantation 1995,62:1384
28. Velosa JA: Strategies to prolong long-term renal allograft function. Transplant Rev 1998,12:1
29. Stegall MD, Everson G, Schroter G, et al: Metabolie complications after liver transplantation: diabetes, h>percholesterol-emia, hypertension and obesity. Transplantation 1995, 60: 1057
30. Wiesner RH, Goldstein RM, DonovanJP, et al: The impact of qtlosporine dose and level on acute rejection and patient and graft survival in liver transplant recipients. Liver Transpl Surgi 998,4:34
31. Padbury RTA, Gunson BK, Doussett B, et al: Steroid withdrawal from long-term immunosuppression in liver allograft recipients. Transplantation 1993,55:789
32. Van Hoek B, \Viesner RH, LudwizJ, et al: Combination immunosuppression with azathioprine reduces the incidence of ductopenic rejection and vanishing bile duct syndrome after liver transplantation. Transplant Proc 1991,23:1403
33. McDiarmid SV, Farmer DA, Goldstein LI, et al: A randomized prospective trial of steroid withdrawal after liver transplantation. Transplantation 1995,60:1443
34. Romani F, Belli LS, De Carlis L, et al: Cyclosporin monotherapy (after 3 months) in liver transplant patients: a prospective randomized trial. Transplant Proc 1994,26:2683
35. Margarit C, Martinez-lbanez V, Tormo R, et al: Maintenance immunosuppression without steroids in pédiatrie liver transplantation. Transplant Proc 1989,21:2230
36. Dunn SP, Falkenstein K, Laurence JP, et al: Monotherapy with cyclosporine for chronic immunosuppression in pédiatrie liver transplant recipients. Transplantation 1994,57:544
37. Andmvs \VS, Shimaoka S, Sommerauer J, et al: Steroid withdrawal after pédiatrie liver transplantation. Transplant Proc 1994,26:159
38. Superina R, Acal L, Bilik R, et al: Growth in children after liver transplantation on cyclosporine alone or in combination with low-dose azathioprine. Transplant Proc 1993,25:2580
39. Higgins RM, Ratcliffe PJ: Hypercholesterolemia and vascular disease after transplantation. Transplant Rev 1991,5:131
40. Levy MF, Goldstein RM, Husberg HH, et al: Baylor update: outcome analysis in liver transplantation, in Terasaki P, CeckaJ (eels) : Clinical Transplants 1993. Los Angeles: UCLA Tissue T>ping I .aboratory, 1991, pl61
41. Stegall MD, Everson GT, Schroter G, et al: Prednisone withdrawal late after adult liver transplantation reduces diabetes, hypertension, and hypercholesterolemia without causing graft loss. I lepatology 1997,25:173
42. Stegall MD, Wachs ME, Everson G, et al: Prednisone withdrawal 14 days after liver transplantation with mycophenolate: a prospective trial of cyclosporine and tacrolimus. Transplantation 1997, &4:1755
43. Ratkovec RM, \Vray RB, Renlund DG, et al: Influence of corticosteroid-free maintenance immunosuppression on allograft coronary arter)' disease after cardiac transplantation. J ThoracCardiovascSurg 1990,100:6
44. Pritzker MR, Lake KD, Reutzel TJ, et al: Steroid-free maintenance immunotherapy: Minneapolis Heat Institute experience. J Heart Lung Transplant 1992,11:415
45. Keogh A, Macdonald P, Harvison A, et al: Initial steroid-free versus steroid-based maintenance therapy and steroid withdrawal after heart transplantation: two views of the steroid question. J Heart Lung Transplant 1992, 11:421
46. KobashigawaJA, Stevenson L\V, Brownfield ED, et al: Initial success of steroid weaning late after heart transplantation. J Heart Lung Transplant 1992,11:431
47. Miller LW, Wolford T, McBride LR, et al: Successful withdrawal of corticosteroids in heart transplantation. J Heart Lung Transplant 1992, 11:428
48. Price GD, Olsen SI, Taylor DO, et al: Corticosteroid-free maintenance immunosuppression after heart transplantation: feasibility and beneficial effects. J Heart Lung Transplant 1992,11:403
49. Renlund DG, Bristow MR, Crandall KG, et al: Hypercholesterolemia after heart transplantation: amelioration by corticosteroid-free maintenance immunosuppression. J Heart Lung Transplant 1989,8:214